Insulin Signaling Disruption and INF-γ Upregulation Induce Aβ 1-42 and Hyperphosphorylated-Tau Proteins Synthesis and Cell Death after Paraquat Treatment of Primary Hippocampal Cells.
Maria Luisa AbascalJavier SanjuanPaula MoyanoEmma SolaAndrea FloresJosé Manuel GarciaJimena GarciaMaría Teresa FrejoJavier Del PinoPublished in: Chemical research in toxicology (2022)
Acute and long-term paraquat (PQ) exposure produces hippocampal neurodegeneration and cognition decline. Although some mechanisms involved in these effects were found, the rest are unknown. PQ treatment, for 1 and 14 days, upregulated interferon-gamma signaling, which reduced insulin levels and downregulated the insulin pathway through phosphorylated-c-Jun N-terminal-kinase upregulation, increasing glucose levels and the production of Aβ 1-42 and phosphorylated-tau, by beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) overexpression and phosphorylated-GSK3β (p-GSK3β; ser9) level reduction, respectively, which induced primary hippocampal neuronal loss. This novel information on the PQ mechanisms leading to hippocampal neurodegeneration could help reveal the PQ actions that lead to cognition dysfunction.
Keyphrases
- type diabetes
- cell death
- cerebral ischemia
- signaling pathway
- cell proliferation
- cell cycle arrest
- pi k akt
- induced apoptosis
- poor prognosis
- mild cognitive impairment
- oxidative stress
- temporal lobe epilepsy
- cerebrospinal fluid
- genome wide
- white matter
- healthcare
- drug induced
- multiple sclerosis
- high glucose
- adipose tissue
- combination therapy
- blood pressure
- subarachnoid hemorrhage
- endoplasmic reticulum stress
- endothelial cells
- social media
- tyrosine kinase
- immune response
- binding protein
- skeletal muscle
- replacement therapy
- health information
- acute respiratory distress syndrome
- stress induced